Medical/Pharmaceuticals

The Menarini Group Announces ELZONRIS® (Tagraxofusp) Designated as an Orphan Drug for BPDCN by Japanese Ministry of Health, Labor and Welfare

* Japanese Ministry of Health, Labor and Welfare grants Orphan Drug Designation to tagraxofusp for blastic plasmacytoid dendritic cell neoplasm (BPDCN) FLORENCE, Italy and NEW YORK, Aug. 30, 2023 /PRNewswire/ -- The Menarini Group ("Menarini"), a leading international pharmaceutical and diagno...

2023-08-30 23:15 3448

European Society of Cardiology Congress: Traditional Chinese Medicine Qili Qiangxin significantly reduces the risk of cardiovascular death and re-hospitalization due to heart failure

AMSTERDAM, Aug. 30, 2023 /PRNewswire/ -- The latest study indicates that adding TCM Qili Qiangxin Capsules (developed and produced by Yiling Pharmaceutical) to the standard of care for heart failure can significantly reduce the risk of re-hospitalization due to worsening heart failure and cardio...

2023-08-30 20:11 3357

LifeTech Scientific Corporation (1302.HK) Announces 2023 Interim Results

SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "Lifetech"), a leading company specialized in minimally invasive interventional medical devices for cardio-cerebrovascular and peripheral vascular diseases, today announced the unaudited consolidated ...

2023-08-30 19:39 6907

Igniting Innovation, Catalyzing Changes: Bio Farma x MIT Hacking Medicine Hackathon Celebrates Success

JAKARTA, Indonesia, Aug. 30, 2023 /PRNewswire/ -- Bio Farma , Indonesia's state-owned pharmaceutical company, has successfully concluded theBio Farma x MIT Hacking Medicine on August 24 to 27, 2023 in Bali. Over the course of four days, the Hackathon oversaw 200 chos...

2023-08-30 16:16 2893

Mindray Introduces Innovative Upgrades to A Series Anaesthesia Systems for Enhanced Patient Safety and Efficiency

SHENZHEN, China, Aug. 30, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in providing advanced medical device solutions, has unveiled upgrades to itsA7 and A5 anaesthesia systems ...

2023-08-30 11:07 5339

Cerecin to Present New Infantile Spasms Data at the 35th International Epilepsy Congress, Dublin 2023

* Data from the pilot study in infantile spasms showed positive outcomes. * The results will be presented by Cerecin's Chief Medical Officer, Dr. Marc Cantillon on Sunday 2nd September at 2pm (GMT+1). * The Cerecin team will be accompanied by PharmaVentures, who will be supporting Cerecin's ...

2023-08-30 00:04 2932

Viva Biotech (1873.HK) Announces 2023 Interim Results:Solid Growth in Main Business, Significant Rebound in Profitability

Highlights of the Interim Results as of June 30, 2023: * Revenue reached RMB1,142.2 million, representing a year-on-year increase of approximately 3.0% * Gross profit amounted to RMB406.0 million, representing a year-on-year increase of approximately 17.7% * Adjusted Non-IFRS net profit amo...

2023-08-29 22:38 3656

Bayer Launches Stunting Prevention Program "CETING" for Community of Cisalak, Depok

DEPOK, Indonesia, Aug. 29, 2023 /PRNewswire/ -- Bayer, a global Life Science company in health and nutrition, is taking an active role in addressing the stunting problem inIndonesia. Coinciding with Bayer's 66th year in Indonesia, Bayer launched the CETING (Prevent Stunting) program for the commu...

2023-08-29 13:53 3276

OTC Hearing Aids Ceretone Bags over $300,000 on Indiegogo, Prepares for Official Sale

ONTARIO, Calif., Aug. 29, 2023 /PRNewswire/ -- Ceretone , a brand under Audicon and a pioneer in the field of Over-the-Counter (OTC) hearing aids, is thrilled to announce the success of its Core One launch campaign on Indiegogo. T...

2023-08-29 09:51 4560

Kelun-Biotech Announces Interim Results for 2023: Global Strategic Partnership and Rich Pipeline Boost Significant Revenue Growth in the First Half of the Year

CHENGDU, China, Aug. 28, 2023 /PRNewswire/ -- Today, Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990.HK), an innovative biopharmaceutical company focusing on the R&D, manufacturing, commercialization, and international cooperation of biotechnology drugs and innovat...

2023-08-28 22:56 6499

Global Times: GT on the spot: An unforgettable record of PLA naval hospital ship's weeklong visit to Solomon Islands

BEIJING, Aug. 28, 2023 /PRNewswire/ -- With groups of people waving goodbye, China's naval hospital ship the Ark Peace sailed from Honiara Harbor on Saturday morning after it successfully concluded its weeklong visit and dispensing medical services to theSolomon Islands. Similar to its arrival, ...

2023-08-28 21:21 2583

Navigating the Future of Neurosurgery: Brain Navi demonstrates NaoTrac and KrystoLens at CNS 2023 & EANS 2023

HSINCHU, Aug. 28, 2023 /PRNewswire/ -- Brain Navi announced today the demonstration of NaoTrac, a neurosurgical navigation robot and KrystoLens, a single-use neuro-endoscope at CNS 2023 inWashington D.C. and EANS 2023 in Barcelona, respectively.

2023-08-28 21:00 2673

Ferinject® granted upgraded recommendations in 2023 ESC heart failure guidelines

The 2023 European Society of Cardiology (ESC) guidelines for acute and chronic heart failure (HF) include upgraded recommendations for intravenous (IV) iron supplementation, including Ferinject® (ferric carboxymaltose), for the management of iron deficiency in patients with HF. Phase IV HEART-FI...

2023-08-28 19:00 3437

3B Scientific acquires iNNOGING Medical

HAMBURG, Germany, Aug. 28, 2023 /PRNewswire/ -- 3B Scientific, a leading manufacturer and marketer of medical simulation products and anatomical models for healthcare education, announces today that it has reached an agreement to acquire iNNOGING Medical. iNNOGING Medical has developed the pione...

2023-08-28 17:13 3704

Jiangsu Recbio Technology Co., Ltd. announced 2023 interim results report and latest progress

TAIZHOU, China, Aug. 28, 2023 /PRNewswire/ -- Innovative vaccine company Recbio (02179.HK) announced its latest progress and interim results for 2023. During the reporting period, the company always adhered to the mission of " Protect Human Health With Best-In-Class Vaccines", rapidly promoted pr...

2023-08-28 11:08 5109

26th World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) - Obesity, bariatric surgery 'cuts' the risk of cancer: -25%

NAPLES, Italy, Aug. 28, 2023 /PRNewswire/ -- Losing weight with bariatric surgery can have a major impact on the risk of developing cancer. A study conducted by theUniversity of Utah, Salt Lake City (USA), published in Obesity, has shown that patients with severe obesity who undergo surgery have ...

2023-08-28 08:00 2505

Antengene Announces Interim Financial Results for 2023 with New Clinical Data Highlighting the Growing Value of Its Pipeline

SHANGHAI and HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), today announced its interim results for the six-months endedJune 30, 2023, and provided updates on multiple milestones achieved since the beginning of 2023. Dr. Jay Mei, Antengene's F...

2023-08-25 19:37 3278

Henlius 2023 H1 Results: Achieved record profits and RMB2.5 billion revenues, opening a new chapter of high-quality growth

SHANGHAI, Aug. 25, 2023 /PRNewswire/ -- Henlius (2696.HK) announced its 2023 interim results. In the first half of 2023, Henlius reported a boost in operating profits ofRMB240.0 million and revenues of RMB2.5005 billion, up by 93.9% YoY, driven by growth in core oncology products. HANQUYOU (trast...

2023-08-25 19:26 7211

AsiaMedic Sets New Standard in Healthcare with Installation of First SIGNA™ Hero 3.0T MRI Scanner in Asia-Pacific

SINGAPORE, Aug. 25, 2023 /PRNewswire/ -- AsiaMedic , a leading health screening and diagnostic imaging specialist, has taken a groundbreaking leap in healthcare innovation with the installation of the first-ever SIGNA™ Hero 3.0T magnetic resonance imaging (MRI) sca...

2023-08-25 14:12 3561

3SBio announces 2023 interim results, with revenue growing over 20% year on year and pipeline value constantly enhanced

HONG KONG, Aug. 25, 2023 /PRNewswire/ -- Chinese leading biopharmaceutical company 3SBio (01530.HK) today released its 2023 interim results. Revenue in the first half of 2023 reached approximatelyRMB3,783.8 million, up 22.3% on a yearly basis. Gross profit was approximatelyRMB3,201.6 million, up ...

2023-08-25 10:06 6733
1 ... 224225226227228229230 ... 381

Week's Top Stories